アステラス薬（4503）　Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI (enzalutamide) in Men with Metastatic Hormone-Sensitive Pr 2018/12/21
/-
読み込み中…